nodes	percent_of_prediction	percent_of_DWPC	metapath
Aztreonam—Vascular purpura—Doxorubicin—testicular cancer	0.00199	0.00199	CcSEcCtD
Aztreonam—Urticaria—Bleomycin—testicular cancer	0.00199	0.00199	CcSEcCtD
Aztreonam—Body temperature increased—Bleomycin—testicular cancer	0.00198	0.00198	CcSEcCtD
Aztreonam—Dizziness—Vinblastine—testicular cancer	0.00196	0.00196	CcSEcCtD
Aztreonam—Convulsion—Cisplatin—testicular cancer	0.00195	0.00195	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.00195	0.00195	CcSEcCtD
Aztreonam—Diplopia—Epirubicin—testicular cancer	0.00192	0.00192	CcSEcCtD
Aztreonam—Gastrointestinal haemorrhage—Epirubicin—testicular cancer	0.00192	0.00192	CcSEcCtD
Aztreonam—Myalgia—Cisplatin—testicular cancer	0.00192	0.00192	CcSEcCtD
Aztreonam—Feeling abnormal—Dactinomycin—testicular cancer	0.00192	0.00192	CcSEcCtD
Aztreonam—Nausea—Chlorambucil—testicular cancer	0.00192	0.00192	CcSEcCtD
Aztreonam—Paraesthesia—Ifosfamide—testicular cancer	0.00192	0.00192	CcSEcCtD
Aztreonam—Ill-defined disorder—Etoposide—testicular cancer	0.00192	0.00192	CcSEcCtD
Aztreonam—Anaemia—Etoposide—testicular cancer	0.00191	0.00191	CcSEcCtD
Aztreonam—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00191	0.00191	CcSEcCtD
Aztreonam—Dyspnoea—Ifosfamide—testicular cancer	0.0019	0.0019	CcSEcCtD
Aztreonam—Discomfort—Cisplatin—testicular cancer	0.0019	0.0019	CcSEcCtD
Aztreonam—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.00189	0.00189	CcSEcCtD
Aztreonam—Vomiting—Vinblastine—testicular cancer	0.00188	0.00188	CcSEcCtD
Aztreonam—Malaise—Etoposide—testicular cancer	0.00186	0.00186	CcSEcCtD
Aztreonam—Vertigo—Etoposide—testicular cancer	0.00186	0.00186	CcSEcCtD
Aztreonam—Headache—Vinblastine—testicular cancer	0.00185	0.00185	CcSEcCtD
Aztreonam—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.00185	0.00185	CcSEcCtD
Aztreonam—Purpura—Doxorubicin—testicular cancer	0.00185	0.00185	CcSEcCtD
Aztreonam—Abdominal pain—Dactinomycin—testicular cancer	0.00184	0.00184	CcSEcCtD
Aztreonam—Body temperature increased—Dactinomycin—testicular cancer	0.00184	0.00184	CcSEcCtD
Aztreonam—Anaphylactic shock—Cisplatin—testicular cancer	0.00184	0.00184	CcSEcCtD
Aztreonam—Hypersensitivity—Bleomycin—testicular cancer	0.00184	0.00184	CcSEcCtD
Aztreonam—Pain—Ifosfamide—testicular cancer	0.00183	0.00183	CcSEcCtD
Aztreonam—Cough—Etoposide—testicular cancer	0.0018	0.0018	CcSEcCtD
Aztreonam—Thrombocytopenia—Cisplatin—testicular cancer	0.0018	0.0018	CcSEcCtD
Aztreonam—Blood creatinine increased—Epirubicin—testicular cancer	0.0018	0.0018	CcSEcCtD
Aztreonam—Asthenia—Bleomycin—testicular cancer	0.00179	0.00179	CcSEcCtD
Aztreonam—Convulsion—Etoposide—testicular cancer	0.00179	0.00179	CcSEcCtD
Aztreonam—Diplopia—Doxorubicin—testicular cancer	0.00178	0.00178	CcSEcCtD
Aztreonam—Gastrointestinal haemorrhage—Doxorubicin—testicular cancer	0.00178	0.00178	CcSEcCtD
Aztreonam—Hyperhidrosis—Cisplatin—testicular cancer	0.00178	0.00178	CcSEcCtD
Aztreonam—Pruritus—Bleomycin—testicular cancer	0.00177	0.00177	CcSEcCtD
Aztreonam—Feeling abnormal—Ifosfamide—testicular cancer	0.00176	0.00176	CcSEcCtD
Aztreonam—Chest pain—Etoposide—testicular cancer	0.00176	0.00176	CcSEcCtD
Aztreonam—Eosinophilia—Methotrexate—testicular cancer	0.00176	0.00176	CcSEcCtD
Aztreonam—Nausea—Vinblastine—testicular cancer	0.00176	0.00176	CcSEcCtD
Aztreonam—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00175	0.00175	CcSEcCtD
Aztreonam—Discomfort—Etoposide—testicular cancer	0.00174	0.00174	CcSEcCtD
Aztreonam—Aspartate aminotransferase increased—Epirubicin—testicular cancer	0.00173	0.00173	CcSEcCtD
Aztreonam—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.00173	0.00173	CcSEcCtD
Aztreonam—Hypotension—Cisplatin—testicular cancer	0.00172	0.00172	CcSEcCtD
Aztreonam—Hypersensitivity—Dactinomycin—testicular cancer	0.00172	0.00172	CcSEcCtD
Aztreonam—Confusional state—Etoposide—testicular cancer	0.0017	0.0017	CcSEcCtD
Aztreonam—Alanine aminotransferase increased—Epirubicin—testicular cancer	0.0017	0.0017	CcSEcCtD
Aztreonam—Urticaria—Ifosfamide—testicular cancer	0.0017	0.0017	CcSEcCtD
Aztreonam—Abdominal pain—Ifosfamide—testicular cancer	0.00169	0.00169	CcSEcCtD
Aztreonam—Body temperature increased—Ifosfamide—testicular cancer	0.00169	0.00169	CcSEcCtD
Aztreonam—Pancytopenia—Methotrexate—testicular cancer	0.00169	0.00169	CcSEcCtD
Aztreonam—Anaphylactic shock—Etoposide—testicular cancer	0.00169	0.00169	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00168	0.00168	CcSEcCtD
Aztreonam—Abdominal distension—Epirubicin—testicular cancer	0.00167	0.00167	CcSEcCtD
Aztreonam—Asthenia—Dactinomycin—testicular cancer	0.00167	0.00167	CcSEcCtD
Aztreonam—Blood creatinine increased—Doxorubicin—testicular cancer	0.00167	0.00167	CcSEcCtD
Aztreonam—Neutropenia—Methotrexate—testicular cancer	0.00166	0.00166	CcSEcCtD
Aztreonam—Paraesthesia—Cisplatin—testicular cancer	0.00165	0.00165	CcSEcCtD
Aztreonam—Thrombocytopenia—Etoposide—testicular cancer	0.00165	0.00165	CcSEcCtD
Aztreonam—Eosinophilia—Epirubicin—testicular cancer	0.00165	0.00165	CcSEcCtD
Aztreonam—Dyspnoea—Cisplatin—testicular cancer	0.00164	0.00164	CcSEcCtD
Aztreonam—Hyperhidrosis—Etoposide—testicular cancer	0.00163	0.00163	CcSEcCtD
Aztreonam—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.0016	0.0016	CcSEcCtD
Aztreonam—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.0016	0.0016	CcSEcCtD
Aztreonam—Diarrhoea—Dactinomycin—testicular cancer	0.00159	0.00159	CcSEcCtD
Aztreonam—Vomiting—Bleomycin—testicular cancer	0.00159	0.00159	CcSEcCtD
Aztreonam—Pancytopenia—Epirubicin—testicular cancer	0.00158	0.00158	CcSEcCtD
Aztreonam—Hypotension—Etoposide—testicular cancer	0.00158	0.00158	CcSEcCtD
Aztreonam—Rash—Bleomycin—testicular cancer	0.00158	0.00158	CcSEcCtD
Aztreonam—Pain—Cisplatin—testicular cancer	0.00157	0.00157	CcSEcCtD
Aztreonam—Dermatitis—Bleomycin—testicular cancer	0.00157	0.00157	CcSEcCtD
Aztreonam—Hypersensitivity—Ifosfamide—testicular cancer	0.00157	0.00157	CcSEcCtD
Aztreonam—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Aztreonam—Neutropenia—Epirubicin—testicular cancer	0.00155	0.00155	CcSEcCtD
Aztreonam—Abdominal distension—Doxorubicin—testicular cancer	0.00155	0.00155	CcSEcCtD
Aztreonam—Stomatitis—Methotrexate—testicular cancer	0.00154	0.00154	CcSEcCtD
Aztreonam—Asthenia—Ifosfamide—testicular cancer	0.00153	0.00153	CcSEcCtD
Aztreonam—Eosinophilia—Doxorubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Aztreonam—Feeling abnormal—Cisplatin—testicular cancer	0.00152	0.00152	CcSEcCtD
Aztreonam—Paraesthesia—Etoposide—testicular cancer	0.00151	0.00151	CcSEcCtD
Aztreonam—Pruritus—Ifosfamide—testicular cancer	0.00151	0.00151	CcSEcCtD
Aztreonam—Dyspnoea—Etoposide—testicular cancer	0.0015	0.0015	CcSEcCtD
Aztreonam—Nausea—Bleomycin—testicular cancer	0.00148	0.00148	CcSEcCtD
Aztreonam—Vomiting—Dactinomycin—testicular cancer	0.00148	0.00148	CcSEcCtD
Aztreonam—Rash—Dactinomycin—testicular cancer	0.00147	0.00147	CcSEcCtD
Aztreonam—Diarrhoea—Ifosfamide—testicular cancer	0.00146	0.00146	CcSEcCtD
Aztreonam—Pancytopenia—Doxorubicin—testicular cancer	0.00146	0.00146	CcSEcCtD
Aztreonam—Body temperature increased—Cisplatin—testicular cancer	0.00146	0.00146	CcSEcCtD
Aztreonam—Jaundice—Epirubicin—testicular cancer	0.00144	0.00144	CcSEcCtD
Aztreonam—Stomatitis—Epirubicin—testicular cancer	0.00144	0.00144	CcSEcCtD
Aztreonam—Pain—Etoposide—testicular cancer	0.00144	0.00144	CcSEcCtD
Aztreonam—Neutropenia—Doxorubicin—testicular cancer	0.00144	0.00144	CcSEcCtD
Aztreonam—Haemoglobin—Methotrexate—testicular cancer	0.00143	0.00143	CcSEcCtD
Aztreonam—Haemorrhage—Methotrexate—testicular cancer	0.00142	0.00142	CcSEcCtD
Aztreonam—Hepatitis—Methotrexate—testicular cancer	0.00142	0.00142	CcSEcCtD
Aztreonam—Dizziness—Ifosfamide—testicular cancer	0.00141	0.00141	CcSEcCtD
Aztreonam—Feeling abnormal—Etoposide—testicular cancer	0.00139	0.00139	CcSEcCtD
Aztreonam—Nausea—Dactinomycin—testicular cancer	0.00138	0.00138	CcSEcCtD
Aztreonam—Gastrointestinal pain—Etoposide—testicular cancer	0.00138	0.00138	CcSEcCtD
Aztreonam—Vomiting—Ifosfamide—testicular cancer	0.00136	0.00136	CcSEcCtD
Aztreonam—Hypersensitivity—Cisplatin—testicular cancer	0.00136	0.00136	CcSEcCtD
Aztreonam—Rash—Ifosfamide—testicular cancer	0.00135	0.00135	CcSEcCtD
Aztreonam—Dermatitis—Ifosfamide—testicular cancer	0.00135	0.00135	CcSEcCtD
Aztreonam—Erythema multiforme—Methotrexate—testicular cancer	0.00134	0.00134	CcSEcCtD
Aztreonam—Urticaria—Etoposide—testicular cancer	0.00134	0.00134	CcSEcCtD
Aztreonam—Haemoglobin—Epirubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Aztreonam—Jaundice—Doxorubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Aztreonam—Stomatitis—Doxorubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Aztreonam—Abdominal pain—Etoposide—testicular cancer	0.00133	0.00133	CcSEcCtD
Aztreonam—Body temperature increased—Etoposide—testicular cancer	0.00133	0.00133	CcSEcCtD
Aztreonam—Haemorrhage—Epirubicin—testicular cancer	0.00133	0.00133	CcSEcCtD
Aztreonam—Hepatitis—Epirubicin—testicular cancer	0.00133	0.00133	CcSEcCtD
Aztreonam—Tinnitus—Methotrexate—testicular cancer	0.00133	0.00133	CcSEcCtD
Aztreonam—Asthenia—Cisplatin—testicular cancer	0.00132	0.00132	CcSEcCtD
Aztreonam—Nausea—Ifosfamide—testicular cancer	0.00127	0.00127	CcSEcCtD
Aztreonam—Diarrhoea—Cisplatin—testicular cancer	0.00126	0.00126	CcSEcCtD
Aztreonam—Erythema multiforme—Epirubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Aztreonam—Hypersensitivity—Etoposide—testicular cancer	0.00124	0.00124	CcSEcCtD
Aztreonam—Tinnitus—Epirubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Aztreonam—Erythema—Methotrexate—testicular cancer	0.00124	0.00124	CcSEcCtD
Aztreonam—Haemoglobin—Doxorubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Aztreonam—Flushing—Epirubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Aztreonam—Haemorrhage—Doxorubicin—testicular cancer	0.00123	0.00123	CcSEcCtD
Aztreonam—Hepatitis—Doxorubicin—testicular cancer	0.00123	0.00123	CcSEcCtD
Aztreonam—Dysgeusia—Methotrexate—testicular cancer	0.00121	0.00121	CcSEcCtD
Aztreonam—Asthenia—Etoposide—testicular cancer	0.00121	0.00121	CcSEcCtD
Aztreonam—Pruritus—Etoposide—testicular cancer	0.00119	0.00119	CcSEcCtD
Aztreonam—Vomiting—Cisplatin—testicular cancer	0.00117	0.00117	CcSEcCtD
Aztreonam—Erythema multiforme—Doxorubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Aztreonam—Rash—Cisplatin—testicular cancer	0.00116	0.00116	CcSEcCtD
Aztreonam—Dermatitis—Cisplatin—testicular cancer	0.00116	0.00116	CcSEcCtD
Aztreonam—Erythema—Epirubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Aztreonam—Diarrhoea—Etoposide—testicular cancer	0.00115	0.00115	CcSEcCtD
Aztreonam—Ill-defined disorder—Methotrexate—testicular cancer	0.00115	0.00115	CcSEcCtD
Aztreonam—Tinnitus—Doxorubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Aztreonam—Anaemia—Methotrexate—testicular cancer	0.00114	0.00114	CcSEcCtD
Aztreonam—Flushing—Doxorubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Aztreonam—Dysgeusia—Epirubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Aztreonam—Malaise—Methotrexate—testicular cancer	0.00112	0.00112	CcSEcCtD
Aztreonam—Dizziness—Etoposide—testicular cancer	0.00112	0.00112	CcSEcCtD
Aztreonam—Vertigo—Methotrexate—testicular cancer	0.00111	0.00111	CcSEcCtD
Aztreonam—Nausea—Cisplatin—testicular cancer	0.00109	0.00109	CcSEcCtD
Aztreonam—Cough—Methotrexate—testicular cancer	0.00108	0.00108	CcSEcCtD
Aztreonam—Ill-defined disorder—Epirubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Aztreonam—Convulsion—Methotrexate—testicular cancer	0.00107	0.00107	CcSEcCtD
Aztreonam—Vomiting—Etoposide—testicular cancer	0.00107	0.00107	CcSEcCtD
Aztreonam—Erythema—Doxorubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Aztreonam—Anaemia—Epirubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Aztreonam—Rash—Etoposide—testicular cancer	0.00106	0.00106	CcSEcCtD
Aztreonam—Dermatitis—Etoposide—testicular cancer	0.00106	0.00106	CcSEcCtD
Aztreonam—Headache—Etoposide—testicular cancer	0.00106	0.00106	CcSEcCtD
Aztreonam—Myalgia—Methotrexate—testicular cancer	0.00105	0.00105	CcSEcCtD
Aztreonam—Chest pain—Methotrexate—testicular cancer	0.00105	0.00105	CcSEcCtD
Aztreonam—Dysgeusia—Doxorubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Aztreonam—Malaise—Epirubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Aztreonam—Discomfort—Methotrexate—testicular cancer	0.00104	0.00104	CcSEcCtD
Aztreonam—Vertigo—Epirubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Aztreonam—Confusional state—Methotrexate—testicular cancer	0.00102	0.00102	CcSEcCtD
Aztreonam—Cough—Epirubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Aztreonam—Anaphylactic shock—Methotrexate—testicular cancer	0.00101	0.00101	CcSEcCtD
Aztreonam—Convulsion—Epirubicin—testicular cancer	0.001	0.001	CcSEcCtD
Aztreonam—Nausea—Etoposide—testicular cancer	0.001	0.001	CcSEcCtD
Aztreonam—Ill-defined disorder—Doxorubicin—testicular cancer	0.000995	0.000995	CcSEcCtD
Aztreonam—Anaemia—Doxorubicin—testicular cancer	0.000991	0.000991	CcSEcCtD
Aztreonam—Thrombocytopenia—Methotrexate—testicular cancer	0.000989	0.000989	CcSEcCtD
Aztreonam—Myalgia—Epirubicin—testicular cancer	0.000986	0.000986	CcSEcCtD
Aztreonam—Chest pain—Epirubicin—testicular cancer	0.000986	0.000986	CcSEcCtD
Aztreonam—Hyperhidrosis—Methotrexate—testicular cancer	0.000977	0.000977	CcSEcCtD
Aztreonam—Discomfort—Epirubicin—testicular cancer	0.000974	0.000974	CcSEcCtD
Aztreonam—Malaise—Doxorubicin—testicular cancer	0.000967	0.000967	CcSEcCtD
Aztreonam—Vertigo—Doxorubicin—testicular cancer	0.000963	0.000963	CcSEcCtD
Aztreonam—Confusional state—Epirubicin—testicular cancer	0.000953	0.000953	CcSEcCtD
Aztreonam—Anaphylactic shock—Epirubicin—testicular cancer	0.000945	0.000945	CcSEcCtD
Aztreonam—Hypotension—Methotrexate—testicular cancer	0.000944	0.000944	CcSEcCtD
Aztreonam—Cough—Doxorubicin—testicular cancer	0.000935	0.000935	CcSEcCtD
Aztreonam—Convulsion—Doxorubicin—testicular cancer	0.000929	0.000929	CcSEcCtD
Aztreonam—Thrombocytopenia—Epirubicin—testicular cancer	0.000926	0.000926	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00092	0.00092	CcSEcCtD
Aztreonam—Hyperhidrosis—Epirubicin—testicular cancer	0.000914	0.000914	CcSEcCtD
Aztreonam—Insomnia—Methotrexate—testicular cancer	0.000914	0.000914	CcSEcCtD
Aztreonam—Chest pain—Doxorubicin—testicular cancer	0.000913	0.000913	CcSEcCtD
Aztreonam—Myalgia—Doxorubicin—testicular cancer	0.000913	0.000913	CcSEcCtD
Aztreonam—Paraesthesia—Methotrexate—testicular cancer	0.000907	0.000907	CcSEcCtD
Aztreonam—Discomfort—Doxorubicin—testicular cancer	0.000902	0.000902	CcSEcCtD
Aztreonam—Dyspnoea—Methotrexate—testicular cancer	0.000901	0.000901	CcSEcCtD
Aztreonam—Hypotension—Epirubicin—testicular cancer	0.000883	0.000883	CcSEcCtD
Aztreonam—Confusional state—Doxorubicin—testicular cancer	0.000882	0.000882	CcSEcCtD
Aztreonam—Anaphylactic shock—Doxorubicin—testicular cancer	0.000875	0.000875	CcSEcCtD
Aztreonam—Pain—Methotrexate—testicular cancer	0.000864	0.000864	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000861	0.000861	CcSEcCtD
Aztreonam—Thrombocytopenia—Doxorubicin—testicular cancer	0.000857	0.000857	CcSEcCtD
Aztreonam—Insomnia—Epirubicin—testicular cancer	0.000855	0.000855	CcSEcCtD
Aztreonam—Paraesthesia—Epirubicin—testicular cancer	0.000849	0.000849	CcSEcCtD
Aztreonam—Hyperhidrosis—Doxorubicin—testicular cancer	0.000846	0.000846	CcSEcCtD
Aztreonam—Dyspnoea—Epirubicin—testicular cancer	0.000843	0.000843	CcSEcCtD
Aztreonam—Feeling abnormal—Methotrexate—testicular cancer	0.000833	0.000833	CcSEcCtD
Aztreonam—Gastrointestinal pain—Methotrexate—testicular cancer	0.000826	0.000826	CcSEcCtD
Aztreonam—Hypotension—Doxorubicin—testicular cancer	0.000817	0.000817	CcSEcCtD
Aztreonam—Pain—Epirubicin—testicular cancer	0.000808	0.000808	CcSEcCtD
Aztreonam—Urticaria—Methotrexate—testicular cancer	0.000803	0.000803	CcSEcCtD
Aztreonam—Abdominal pain—Methotrexate—testicular cancer	0.000799	0.000799	CcSEcCtD
Aztreonam—Body temperature increased—Methotrexate—testicular cancer	0.000799	0.000799	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000797	0.000797	CcSEcCtD
Aztreonam—Insomnia—Doxorubicin—testicular cancer	0.000791	0.000791	CcSEcCtD
Aztreonam—Paraesthesia—Doxorubicin—testicular cancer	0.000786	0.000786	CcSEcCtD
Aztreonam—Dyspnoea—Doxorubicin—testicular cancer	0.00078	0.00078	CcSEcCtD
Aztreonam—Feeling abnormal—Epirubicin—testicular cancer	0.000779	0.000779	CcSEcCtD
Aztreonam—Gastrointestinal pain—Epirubicin—testicular cancer	0.000773	0.000773	CcSEcCtD
Aztreonam—Urticaria—Epirubicin—testicular cancer	0.000751	0.000751	CcSEcCtD
Aztreonam—Pain—Doxorubicin—testicular cancer	0.000748	0.000748	CcSEcCtD
Aztreonam—Abdominal pain—Epirubicin—testicular cancer	0.000747	0.000747	CcSEcCtD
Aztreonam—Body temperature increased—Epirubicin—testicular cancer	0.000747	0.000747	CcSEcCtD
Aztreonam—Hypersensitivity—Methotrexate—testicular cancer	0.000744	0.000744	CcSEcCtD
Aztreonam—Asthenia—Methotrexate—testicular cancer	0.000725	0.000725	CcSEcCtD
Aztreonam—Feeling abnormal—Doxorubicin—testicular cancer	0.000721	0.000721	CcSEcCtD
Aztreonam—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000715	0.000715	CcSEcCtD
Aztreonam—Pruritus—Methotrexate—testicular cancer	0.000715	0.000715	CcSEcCtD
Aztreonam—Hypersensitivity—Epirubicin—testicular cancer	0.000697	0.000697	CcSEcCtD
Aztreonam—Urticaria—Doxorubicin—testicular cancer	0.000695	0.000695	CcSEcCtD
Aztreonam—Abdominal pain—Doxorubicin—testicular cancer	0.000692	0.000692	CcSEcCtD
Aztreonam—Body temperature increased—Doxorubicin—testicular cancer	0.000692	0.000692	CcSEcCtD
Aztreonam—Diarrhoea—Methotrexate—testicular cancer	0.000691	0.000691	CcSEcCtD
Aztreonam—Asthenia—Epirubicin—testicular cancer	0.000678	0.000678	CcSEcCtD
Aztreonam—Pruritus—Epirubicin—testicular cancer	0.000669	0.000669	CcSEcCtD
Aztreonam—Dizziness—Methotrexate—testicular cancer	0.000668	0.000668	CcSEcCtD
Aztreonam—Diarrhoea—Epirubicin—testicular cancer	0.000647	0.000647	CcSEcCtD
Aztreonam—Hypersensitivity—Doxorubicin—testicular cancer	0.000645	0.000645	CcSEcCtD
Aztreonam—Vomiting—Methotrexate—testicular cancer	0.000642	0.000642	CcSEcCtD
Aztreonam—Rash—Methotrexate—testicular cancer	0.000637	0.000637	CcSEcCtD
Aztreonam—Dermatitis—Methotrexate—testicular cancer	0.000636	0.000636	CcSEcCtD
Aztreonam—Headache—Methotrexate—testicular cancer	0.000633	0.000633	CcSEcCtD
Aztreonam—Asthenia—Doxorubicin—testicular cancer	0.000628	0.000628	CcSEcCtD
Aztreonam—Dizziness—Epirubicin—testicular cancer	0.000625	0.000625	CcSEcCtD
Aztreonam—Pruritus—Doxorubicin—testicular cancer	0.000619	0.000619	CcSEcCtD
Aztreonam—Vomiting—Epirubicin—testicular cancer	0.000601	0.000601	CcSEcCtD
Aztreonam—Nausea—Methotrexate—testicular cancer	0.0006	0.0006	CcSEcCtD
Aztreonam—Diarrhoea—Doxorubicin—testicular cancer	0.000599	0.000599	CcSEcCtD
Aztreonam—Rash—Epirubicin—testicular cancer	0.000596	0.000596	CcSEcCtD
Aztreonam—Dermatitis—Epirubicin—testicular cancer	0.000596	0.000596	CcSEcCtD
Aztreonam—Headache—Epirubicin—testicular cancer	0.000592	0.000592	CcSEcCtD
Aztreonam—Dizziness—Doxorubicin—testicular cancer	0.000578	0.000578	CcSEcCtD
Aztreonam—Nausea—Epirubicin—testicular cancer	0.000562	0.000562	CcSEcCtD
Aztreonam—Vomiting—Doxorubicin—testicular cancer	0.000556	0.000556	CcSEcCtD
Aztreonam—Rash—Doxorubicin—testicular cancer	0.000552	0.000552	CcSEcCtD
Aztreonam—Dermatitis—Doxorubicin—testicular cancer	0.000551	0.000551	CcSEcCtD
Aztreonam—Headache—Doxorubicin—testicular cancer	0.000548	0.000548	CcSEcCtD
Aztreonam—Nausea—Doxorubicin—testicular cancer	0.00052	0.00052	CcSEcCtD
